Mahamaya Lifesciences executives featured in AgroPages interview
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.2 pts less than Nifty Microcap 250 and 1.0 pts more than its Pesticides & Agrochemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Mahamaya Lifesciences informed BSE that an interview with its Managing Director and Executive Director was published in the AgroPages 2026 India Focus Issue. The interview discusses FY2025-26 results (revenue Rs 328.87 crore, up 24.5 percent; EBITDA Rs 34.26 crore, up 32.6 percent; PAT Rs 16.52 crore, up 29 percent), Dahej technical manufacturing facility progress, IPO capital deployment, domestic branded expansion into Central India, and export registrations across around 10 countries including the UAE, Egypt, Turkey, and Australia.
No fresh material disclosure; this is a public relations filing about a published interview covering past results and strategy.